Evidence map›Paper›PMID 34292303›Full record

ArticleThe Journal of cell biology2021

Signal strength controls the rate of polarization within CTLs during killing.

Gordon L Frazer, Christian M Gawden-Bone, Nele M G Dieckmann, Yukako Asano, Gillian M Griffiths

Abstract read
In one paragraph

Article in The Journal of cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Frontiers in immunology · 2022
    Review
  9. The Era of Cytotoxic CD4 T Cells.Frontiers in immunology · 2022
    Review
  10. The Expanding Arsenal of Cytotoxic T Cells.Frontiers in immunology · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gordon L FrazerCambridge Institute for Medical Research, Biomedical Campus, Cambridge, UK.ORCID 0000-0003-4359-4606
Christian M Gawden-BoneCambridge Institute for Medical Research, Biomedical Campus, Cambridge, UK.ORCID 0000-0003-0413-3727
Nele M G DieckmannCambridge Institute for Medical Research, Biomedical Campus, Cambridge, UK.
Yukako AsanoCambridge Institute for Medical Research, Biomedical Campus, Cambridge, UK.ORCID 0000-0002-0753-1280
Gillian M GriffithsCambridge Institute for Medical Research, Biomedical Campus, Cambridge, UK.ORCID 0000-0003-0434-5842

Funding

Wellcome Trust 097024Wellcome Trust 099789Wellcome Trust 100140Wellcome Trust 103930Wellcome Trust 217100
6 · The paper itself

Abstract

Cytotoxic T lymphocytes (CTLs) are key effector cells in the immune response against viruses and cancers, killing targets with high precision. Target cell recognition by CTL triggers rapid polarization of intracellular organelles toward the synapse formed with the target cell, delivering cytolytic granules to the immune synapse. Single amino acid changes within peptides binding MHC class I (pMHCs) are sufficient to modulate the degree of killing, but exactly how this impacts the choreography of centrosome polarization and granule delivery to the target cell remains poorly characterized. Here we use 4D imaging and find that the pathways orchestrating killing within CTL are conserved irrespective of the signal strength. However, the rate of initiation along these pathways varies with signal strength. We find that increased strength of signal leads to an increased proportion of CTLs with prolonged dwell times, initial Ca2+ fluxes, centrosome docking, and granule polarization. Hence, TCR signal strength modulates the rate but not organization of effector CTL responses.

Indexed as

AnimalsCalciumCells, CulturedCentrosomeMiceMice, Inbred C57BLMice, KnockoutSignal TransductionSynapsesT-Lymphocytes, CytotoxicCalcium

Identifiers

PMID34292303
PMCPMC8302442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.